TPIV Market Cap History
Below is a table of the TPIV market cap history going back to 9/16/2016:

Date TPIV Market Cap
9/16/201646.48M
11/2/201641.48M
11/8/201645.92M
3/13/201738.99M
5/2/201734.90M
8/2/201730.68M
11/1/201730.25M
3/16/201838.79M
5/11/201830.77M
8/2/2018107.49M

Also see: TPIV Shares Outstanding History
and TPIV YTD Return
TPIV Historical Market Cap:
+56.31% CAGR
TPIV Historical Market Cap: +56.31% CAGR

Mouse over chart for data details
9/16/201611/2/201611/8/20163/13/20175/2/20178/2/201711/1/20173/16/20185/11/20188/2/2018
Marker Therapeutics is a clinical-stage immuno-oncology company. Co. focuses on the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease, as well as develops DNA expression technology. Co. is developing vaccines that target candidate breast cancer(s), colorectal cancer(s), ovarian cancer(s) and non-small cell lung cancer(s). Co.'s three primary technology platforms include: a licensed vaccine for the treatment of HER2/neu+ breast cancer; a licensed vaccine for treating breast and ovarian cancers; and a wholly owned DNA expression vaccine technology (Polystart) for treating various cancers or infectious disease. We show 10 historical shares outstanding datapoints in our TPIV shares outstanding history coverage, used to compute TPIV market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TPIV market cap history over the course of time is important for investors interested in comparing TPIV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TPIV versus a peer is one thing; comparing TPIV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TPIV can fluctuate over the course of history. With this page we aim to empower investors researching TPIV by allowing them to research the TPIV market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for TPIV:
TPIV SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
TapImmune (TPIV) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TRNX Market Cap History
TROV Market Cap History
TRVN Market Cap History
TSRO Market Cap History
TTNP Market Cap History
TTOO Market Cap History
TTPH Market Cap History
TVTY Market Cap History
TXMD Market Cap History
TYME Market Cap History
More Healthcare companies »

 

TPIV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.